Clinical OMICs - Issue 8 - (Page 19)
Image © fotohunter/iStock
The growth of genomic medicine has cast a
spotlight on the need for higher-resolution
technologies for chromosomal analysis.
been used as the definitive diagnostic test for microdeletion/duplication
disorders such as Williams syndrome
and 22q11.2 deletion (DiGeorge/
velocardiofacial) syndrome, as well as
submicroscopic chromosomal rearrangements involving the subtelomeric regions that cause congenital
abnormalities and developmental
disabilities. FISH however, can only
detect deletions or duplications of
regions specifically targeted by the
probe used and which are larger than
the probe. The technique, therefore,
may miss small deletions.
Copy Number Variation
As copy number variation (CNV) has
been increasingly recognized as playing a role in such human diseases as
obesity, heart disease, cancer, autism,
and schizophrenia, and as a major
cause of structural variation in the
genome, the need for higher-resolution technologies for chromosomal
analysis has emerged. CNVs involve
both duplications and deletions of
www.clinicalomics.com
sequences that typically range in relatively rare variants that are much
length from 1,000-5,000,000 base longer than CNPs, ranging in size from
pairs, in many cases below the cyto- hundreds of thousands of base pairs
genetic level of resolution.
to over 1 million base pairs in length.
Based on the length of the affected Also known as microdeletions and
sequence, scientists assign CNVs microduplications, these large and
to one of two main categories. The rare structural variants occur disprofirst includes copy number polymor- portionately in patients with mental
phisms (CNPs), found
retardation, developcommonly in the genmental delay, schizoCNV has been
eral population, at
phrenia, and autism,
an overall frequency
suggesting to some
increasingly recognized
of greater than 1%.
scientists that their
as playing a role in
CNPs are typically
appearance in such
such human diseases as
small (most are less
patients has led to
obesity, heart disease,
than 10 kilobases in
speculation that large
cancer, autism, and
length), and they are
and rare CNVs may
schizophrenia.
often enriched for
be more important in
genes that encode
neurocognitive disproteins important in drug detoxifica- eases than other forms of inherited
tion and immunity. CNPs associated mutations, including single nucleowith immune response genes have tide substitutions.
recently been associated with suscepCNVs, which result from larger-scale
tibility to complex genetic diseases, genomic events such as deletions,
including psoriasis, Crohn's disease, duplications, inversions, and transloand glomerulonephritis.
cations, occur more commonly than
The second class of CNVs includes (continued on next page)
August 13, 2014 Clinical OMICs
19
http://www.clinicalomics.com
Table of Contents for the Digital Edition of Clinical OMICs - Issue 8
Contents
Clinical OMICs - Issue 8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss9
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss7
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss6
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss4
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss2
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol3iss1
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss12
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss11
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss10
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss9
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss7
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss6
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss4
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss2
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_vol2iss1
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue15
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue14
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue13
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue12
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue11
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue10
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue9
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue8
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue7
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue6
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue5
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue4
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue3
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue2
https://www.nxtbook.com/nxtbooks/gen/clinical_omics_issue1
https://www.nxtbookmedia.com